Media headlines about Synopsys (NASDAQ:SNPS) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Synopsys earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned news coverage about the semiconductor company an impact score of 45.596661480842 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:
- Synopsys, Inc. (SNPS) : Stock in the Analysts Spotlight – Wall Street Morning (wallstreetmorning.com)
- Technical indicators to predict the future price movements of Synopsys, Inc. (SNPS) – Wall Street Morning (wallstreetmorning.com)
- Synopsys, Inc. (SNPS) Director Chrysostomos L. Nikias Sells 21,073 Shares (americanbankingnews.com)
- Why Is Synopsys (SNPS) Down 1.8% Since the Last Earnings … – Nasdaq (nasdaq.com)
- Why Is Synopsys (SNPS) Down 1.8% Since the Last Earnings Report? (finance.yahoo.com)
Synopsys (NASDAQ SNPS) traded up $0.83 during mid-day trading on Thursday, reaching $87.89. The company’s stock had a trading volume of 1,059,902 shares, compared to its average volume of 973,900. The company has a market cap of $13,180.00, a PE ratio of 102.20, a PEG ratio of 3.83 and a beta of 1.01. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.04 and a current ratio of 1.04. Synopsys has a 52-week low of $59.41 and a 52-week high of $94.80.
A number of analysts recently commented on SNPS shares. TheStreet cut shares of Synopsys from an “a” rating to a “c+” rating in a research report on Wednesday, November 29th. Zacks Investment Research upgraded shares of Synopsys from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a research report on Tuesday, October 3rd. Needham & Company LLC upped their price objective on shares of Synopsys from $83.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, December 1st. JPMorgan Chase & Co. restated an “underweight” rating on shares of Synopsys in a research report on Thursday, December 7th. Finally, KeyCorp restated an “overweight” rating and issued a $106.00 price objective (up previously from $86.00) on shares of Synopsys in a research report on Thursday, November 30th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $96.89.
In other Synopsys news, EVP Joseph W. Logan sold 5,000 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $90.33, for a total transaction of $451,650.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Chrysostomos L. Nikias sold 21,073 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $85.88, for a total value of $1,809,749.24. Following the transaction, the director now owns 32,466 shares of the company’s stock, valued at approximately $2,788,180.08. The disclosure for this sale can be found here. In the last quarter, insiders have sold 60,897 shares of company stock valued at $5,370,098. Corporate insiders own 1.82% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3126008/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-synopsys-snps-stock-price.html.
Synopsys, Inc provides software, intellectual property (IP) and services. The Company supplies the electronic design automation (EDA) software that engineers use to design and test integrated circuits, also known as chips. It also offers IP products, which are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves.
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.